MedPath

The relationship between insomnia, negative affect, and paranoia

Not Applicable
Completed
Conditions
Insomnia, paranoia, negative affect
Mental and Behavioural Disorders
Registration Number
ISRCTN18384206
Lead Sponsor
niversity of Sheffield
Brief Summary

2017 results in https://pubmed.ncbi.nlm.nih.gov/29049381 (added 30/01/2020)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
348
Inclusion Criteria

Participants must be over the age of 18

Exclusion Criteria

1. Under the age of 18
2. Insomnia due to a physical complaint (e.g. back pain)
3. On medication for a mental health problem or sleep complaint
4. Currently receiving psychological therapy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br> Sleep-50 insomnia sub-scale: assessing aspects of insomnia (both falling asleep and staying asleep)<br><br> Each of the outcome measures were completed by all participants before the intervention started (baseline), immediately after the intervention (post-intervention), 4-weeks after the intervention and finally 18 weeks after the intervention<br>
Secondary Outcome Measures
NameTimeMethod
<br> 1. Depression, Anxiety, and Stress Scale-21 (DASS-21): the shortened form of DASS-21 assessing feelings of depression, anxiety and stress, collectively referred to as negative affect<br> 2. Green Paranoid Thoughts Scale part B (GPTS-B): measuring levels of paranoid thinking<br><br> Each of the outcome measures were completed by all participants before the intervention started (baseline), immediately after the intervention (post-intervention), 4-weeks after the intervention and finally 18 weeks after the intervention<br>
© Copyright 2025. All Rights Reserved by MedPath